Prolight Diagnostics has announced a significant achievement in the development of its Psyros point-of-care system. The company has reached assay design freeze for its high-sensitivity troponin cartridge, locking in the final chemical configuration and performance characteristics. This marks a transition from the development phase to manufacturing optimization, setting the stage for the upcoming clinical performance study. BioStock contacted CSO Aileen McGettrick to learn more.
Read the full article at biostock.se:
https://biostock.se/en/2025/12/prolight-diagnostics-nar-assay-design-freeze-for-det-hogkansliga-troponintestet-en-avgorande-milstolpe-for-psyros/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se